{"id":15955,"date":"2026-03-20T15:43:33","date_gmt":"2026-03-20T14:43:33","guid":{"rendered":"https:\/\/blogdelarechercheclinique.com\/?p=15955"},"modified":"2026-03-25T11:00:06","modified_gmt":"2026-03-25T10:00:06","slug":"recherche-clinique-a-madagascar-defis-opportunites-et-avenir-prometteur","status":"publish","type":"post","link":"https:\/\/blogdelarechercheclinique.com\/en\/recherche-clinique-a-madagascar-defis-opportunites-et-avenir-prometteur\/","title":{"rendered":"Clinical Research in Madagascar: Challenges, Opportunities, and a Promising Future"},"content":{"rendered":"

Clinical research is a key driver of medical innovation and public health improvement.<\/strong>

In Madagascar, this field is still emerging. However, discussions at the 20th Indian Ocean HIV Colloquium, particularly during the roundtable we led, highlighted both current challenges and promising prospects for sponsors and investigators willing to engage.<\/p>\n\n\n\n

At the table, we exchanged views with representatives from the Ethics Committee, the Malagasy Medicines Agency, field investigators, the Institut Pasteur de Madagascar, and the National Institute of Public and Community Health. These perspectives allow us to provide a realistic yet forward-looking assessment.<\/p>\n\n\n\n

An Emerging Context<\/strong><\/p>\n\n\n\n

Currently, Madagascar represents a small fraction of clinical trials registered internationally (37 in ClinicalTrials.gov, 85 in the WHO ICTRP). Research funding remains very limited (0.01% of GDP), yet growing interest from public and private institutions shows a genuine willingness to structure the field.<\/p>\n\n\n\n

The country faces diverse health issues: HIV, tuberculosis, malaria, plague, as well as rising chronic conditions such as hypertension and diabetes. This diversity offers a broad scope for interventional and observational studies.<\/p>\n\n\n\n

Key Challenges<\/strong><\/p>\n\n\n\n

    \n
  1. Infrastructure and Human Resources<\/strong>
    Research sites remain limited, and the lack of qualified personnel requires investigators to train their own teams. However, this challenge also presents an opportunity: Madagascar is beginning to consider creating specialized training programs, such as a university diploma in clinical research, to professionalize the workforce.<\/li>\n\n\n\n
  2. Regulatory and Ethical Framework<\/strong>
    Since 2016, Madagascar has had a National Ethics Committee for biomedical research, ensuring participant protection and adherence to international standards. The framework is gradually strengthening, although some procedures still need refinement. Working with experienced providers ensures rapid solutions and smooth compliance.<\/li>\n\n\n\n
  3. Funding<\/strong>
    Local funding is scarce, with most resources coming from international donors (USA, UK, EU). Strong partnerships are key to increasing visibility and attracting research projects.<\/li>\n<\/ol>\n\n\n\n

    Why Madagascar is an Opportunity<\/strong><\/p>\n\n\n\n

      \n
    1. Respectful and Collaborative Research<\/strong> \u2013 Participants are treated as true partners, providing valuable data within an ethical and internationally recognized framework.<\/li>\n\n\n\n
    2. Innovation-Friendly Environment<\/strong> \u2013 The combination of infectious and emerging chronic diseases creates a unique setting to test new medical approaches.<\/li>\n\n\n\n
    3. Growing Local Expertise<\/strong> \u2013 Madagascar has a developing pool of health professionals and researchers capable of conducting rigorous studies.<\/li>\n\n\n\n
    4. Capacity-Building Momentum<\/strong> \u2013 Institutes and hospitals (Institut Pasteur, Charles M\u00e9rieux Infectiology Center, CHU Befelatanana, CHU Fianarantsoa, CHU Toamasina\u2026) train their own teams, and the Public Health Master\u2019s program includes clinical research modules.<\/li>\n\n\n\n
    5. Openness to International Collaboration<\/strong> \u2013 Authorities are integrating clinical research into national priorities, offering sponsors a less competitive but high-potential environment.<\/li>\n<\/ol>\n\n\n\n

      Role of Local Partners<\/strong><\/p>\n\n\n\n

      Since 2020, Pharmaspecific has strengthened local skills through clinical research training. This presence allows us to guide sponsors in:<\/p>\n\n\n\n